Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-57874-6, published online 26 March 2024
In the original version of this Article Guijie Li was incorrectly affiliated with ‘Jinan Center for Disease Control and Prevention, Jinan, Shandong 250000, People’s Republic of China’. The correct affiliation for Guijie Li is listed below.
Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Road, Lixia, Jinan, Shandong 250014, People’s Republic of China.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, H., Gao, C., Li, X. et al. Author Correction: Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma. Sci Rep 14, 8787 (2024). https://doi.org/10.1038/s41598-024-59647-7
Published:
DOI: https://doi.org/10.1038/s41598-024-59647-7
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
